We screened sera from 370 patients suffering from exanthematous illnesses in Belém, North Brazil, for the presence of human herpesvirus-7 (HHV-7) IgM and IgG antibodies. Samples were obtained from January 1996 to December 2002 and were processed by a HHV-7-specific indirect immunofluorescence assay (IFA). HHV-7-specific IgM and/or IgG antibodies were found in 190 (51.4%) of these patients, with similar prevalence rates (IgM+ and IgG+ subgroups taken together) for female and male subjects: 52.5% and 50.3%, respectively. Serological status as defined by IgG was identified in 135 (36.5%) patients. In 55 (14.9%) of the patients HHV-7 IgM antibodies were detected. HHV-7 IgM-and-IgG antibody rates were similar (p > 0.05) when male and female subjects are compared: 14.4% versus 15.3% and 38.1% versus 35.0%, respectively. Statistically significant difference (p = 0.003) was noted when HHV-7-IgM-positive female and male patients aged 5-8 months are compared. Prevalence rates ranging from 4.6% (female, 5-8 months of age) to 93.3% (female, > 10 years of age) and 12.2% (male, 5-8 months) to 80.0% (male, 8-10 years of age) were noted in the IgG-positive subgroups. A subgroup (n = 131) of patients with IgM or IgG HHV-7 antibodies were examined for the presence of DNA using a polymerase chain reaction/nested PCR. Recent/active HHV-7 infection occurred at a rate of 11.0% (6/55) among patients whose samples presented IgM+ specific antibodies. In a subgroup (n = 76) of patients with high HHV-7-IgG antibody levels (titre > 1:160) DNA could not be detected in sera examined by PCR/nested PCR. Of the six recent/active infections, four subjects with less than 1 year and two with 3 and 6 years of age, presented typical exanthem subitum (E.S), as defined by higher fever (> 38.0 ºC) with duration of 24 to 72 hours, followed by a maculopapular skin rash. Our results underscore the need for searching HHV-7 infection in patients with exanthematous diseases, particularly those presenting with typical E.S. HHV-7 appears therefore to emerge as a newly recognized pathogen of exanthem in our region.
INTRODUCTION
Human herpesvirus-7 was first isolated by FRENKEL et al. 15 from activated CD4
+ peripheral blood T cells of a healthy individual in 1990 2, 20, 23 . It is currently known to belong to the β-herpesvirinae subfamily 2, 24 .
HHV-7 is ubiquitous and primary infection occurs mainly during infancy between the ages of 2 to 5 years 3, 6, 39 , therefore later than that of HHV-6 16 . The exanthema subitum (E.S) is the commonest clinical presentation of the HHV-7 infection in infancy and childhood 1, 8, 17, 31, 34 . Serological evidence for primary HHV-7 infection has been obtained from adult patients with pityriasis rosea 14 , aseptic meningitis 24, 42 and chronic fatigue syndrome 13 . In addition to this, neurological disease in children with E.S has been evidenced through the occurrence of febrile convulsions and acute hemiplegia 23, 24, 25, 33, 34, 35 . Childhood HHV-7 recurrent fever has also been reported 1 . Recently, HHV-7 has been isolated from saliva of healthy adults, indicating that salivary glands are a likely site of HHV-7 replication 38 . Studies on the seroprevalence for HHV-7 infection conducted in USA yielded rates that exceed 85.0% 11 . In Japan 41 , seropositivity rates in children aged 1 to 4 and 7 to 8 years were 45.0% and 40.0%, respectively. Also in Japan, primary HHV-7 infection was estimated to occur in 10.2% of patients with clinically diagnosed E.S, as reported by HIDAKA et al. 17 . In a study conducted by BLACK et al. 4 among Brazilian children clinically diagnosed as measles and rubella, patients' sera were negative for antibodies to both viruses, but clearly seroconverted to HHV-6 and HHV-7 with 20.0% and 8.0%, respectively.
In this study we report the occurrence of exanthematous illnesses (most of which clinically diagnosed as E.S) associated with primary HHV-7 infection in Belém, Pará, north Brazil.
MATERIAL AND METHODS
The study was conducted in Belém, Pará, Brazil between January 1996 and December 2002. A total of 370 blood samples were collected from individuals presenting with exanthematous illnesses at the Virology Section of Instituto Evandro Chagas. These patients were selected from an overall 2,550 individuals with exanthematous illnesses (high fever and maculopapular skin rash) who tested negative for the following agents: measles, rubella, Epstein-Barr virus, cytomegalovirus, parvovirus B19, human herpesvirus-6 (HHV-6) and arboviruses (Mayaro, Oropouche and dengue). Of the 370 individuals 181 were female and 189 were male, with ages ranging from 3 months to 68 years (mean age, 6 years). Blood samples were collected during acute phase of disease by antecubital venepuncture. All sera were stored frozen at -20 ºC until processed anonimously.
Detection of IgM-and-IgG antibodies to HHV-7 was made using a commercially available immunofluorescence assay (IFA) manufactured by STELLAR BIOSYSTEMS™ (Columbia, USA). This system includes solid-phase multiple-spot slides coated with human lymphocytes infected with HHV-7, as previously described 36 . Sera were tested at a (single) dilution of 1:10 with previous removal of IgG fraction using GullSORB™, Salt Lake City, Utah, USA. This ensures that no interference will occur with rheumatoid factor. Tested samples were regarded as HHV-7-IgM positive when a bright green fluorescent staining could be noted in the infected cells of the screening dilution. The presence of HHV-7 IgM antibody in the samples defined recent infection (the cutoff values for negative and positive results for HHV-7 in sera were less than 1:10 and 1:10, respectively).
A subgroup (n = 131) of subjects with IgM and/or high (> 1:160) IgG antibodies level to HHV-7 were selected for DNA detection using the polymerase chain reaction (PCR). This reaction was performed in two steps, essentially as reported before 18, 37 . A first amplification was done using a mixture of external oligonucleotide primers (MK1 and MK2), followed by a second amplification (nested PCR) that involved a mixture of the internal primers MK3 and MK4. Each PCR reaction was composed of a mixture including 1.5 mM MgCl 2 , 0.5 µM of each primer, and 2.5 units of Taq DNA polymerase (INVITROGEN™) in the final concentration. Thermal cycles were ran as follows: 1 initial cycle at 95 ºC for six min, 40 cycles of denaturation at 94 ºC for thirty seconds, annealing at 50 ºC for thirty seconds, and extension at 72 ºC for thirty seconds. A single final extension step at 72 ºC for ten minutes was developed. HHV-7 active infection was defined as the presence of either IgM or IgG antibodies plus the detection of viral DNA. Concurrently, serological assays were used for the detection of both IgM and IgG antibodies to rubella, measles, Epstein-Barr virus, cytomegalovirus, parvovirus B19 and HHV-6 10, 12, 19, 22, 26, 27 . Serum specimens were also assayed by conventional haemagglutination-inhibition (HI), as described before 29 , for the detection of antibodies to Mayaro, Oropouche and dengue viruses.
Statistical analysis was done with EPI-INFO software, version 6.0 (Atlanta, GA, USA). Comparison of rates between groups was made with the Mantel-Haenszel chi-square test of association or, if assumptions required for the chi-square test were not met, with Fisher's exact test. Siqnificance was defined as p < 0.05.
RESULTS
A total of 190 (51.4%) of the 370 patients had HHV-7-specific IgM and/or IgG antibodies in their sera, whilst 180 (48.6%) subjects were found to be IgM-and-IgG seronegative (Table 1) . Similar rates of HHV-7 antibodies (IgM and/or IgG) were noted for female and male subjects: 52.5% and 50.4%, respectively. Serological status as defined by the presence of HHV-7 IgG antibodies was identified in 135 (36.5%) patients. In addition, 55 (14.9%) of the 370 patients were found to be HHV-7 IgM-positive. Positivity rates for both female and male subjects were compared [14.4% versus 15.3% (IgM+ subgroup) and 35.0% versus 38.1% (IgG+ subgroup)], but no significant differences (p > 0.05) were observed. A significant difference (p = 0.003) was seen when female and male IgM-positive subjects aged 5 to 8 months are compared. Prevalence rates ranging from 4.6% (female, 5-8 months of age) to 93.3% (female, >10 years of age) and 12.2% (male, 5-8 months of age) to 80.0% (male, [8] [9] [10] were noted in the IgG-positive subgroups. The prevalence rates increased across the 5 age-groups, if considered the IgM-positive and IgG-positive subjects. The frequency of the recent/active HHV-7 infection was of 11.0% (6/55) among patients whose sera presented levels of IgM-specific antibodies plus DNA detection (Table 1 ). Of these, four subjects aged less than 1 year and two with 3 and 6 years presented typical E.S. Figure 1 illustrates the nested-PCR displaying the amplified HHV-7 DNA fragments and controls. This analysis included a negative control (lane 1), a positive control (lane 2) and 5 serum samples shown to be DNA-positive (lanes 3-7) . No positive results were obtained from testing sera for potential pathogens other than HHV-7 -including HHV-6 -that might be involved in etiology of the exanthematous illness.
DISCUSSION
Serological studies conducted in both temperate and tropical countries have shown the wide distribution of HHV-7 infection, as well as its association with cases of E.S, mainly in children above 3 years of age and young adults 1, 3, 8, 9, 11, 17, 31, 34, 38 . Investigations conducted in USA 11, 38 and Mexico 21 presented rates of 85.0% and 98.0%, respectively, which are higher than those found in our serosurvey (51.6%). Conversely, in Japan 41 lower prevalence rates, 45.0% and 40.0% for subjects of 1-4 and 7-8 years of age, respectively, were observed. These data suggest that a variation in seroprevalence rates may occur in the different geographical areas. It is likely that methods of sample collection 32 , together with some differences in the techniques 41 used for the diagnosis of the HHV-7 infection may have accounted for such variable results.
It is noteworthy in our study that a decline in the seroprevalence rates for HHV-7 antibodies occurred among individuals of ≤ 4 months and 5-8 months if we consider the IgM-positive and IgG-positive. This trend for a gradual decline in antibody levels may reflect the progressive loss of the maternal antibodies 11, 41 . This situation was not observed in several other studies including one in USA 11, 38 that recorded such occurrences in children aged above 3 years, after they had developed primary HHV-6 infections 7, 8, 11 . In accordance with previous studies 11, 31 , this might be related to the persistence of protecting HHV-7 maternal antibodies for longer than HHV-6 antibodies. This fact may explain the occurrence of two primary HHV-7 infections among children aged 3 and 6 years in the present study. In spite of the four recent/active HHV-7 infections observed in children with less of one year in our investigation, 49.0% to 64.0% of the individuals among 9-12 months, and 26.0% to 46.0% among 2-4 years examined, were still seronegative for the HHV-7. In support to these findings we observed that prevalence rates increased sharply as from two years of age onwards, being of 58.0% to 75.0% in age 5-7 years and 75.0% to 93.0% in > 10 years of age if included those subjects who were IgG-positive only. Analysis of these data leads us to postulate that an epidemiological profile similar to ours was observed mainly in USA and Japan, where primary HHV-7 infections appear to occur later than that by HHV-6 8, 38 , therefore being regarded as the second exanthematous illness during childhood 32 .
In this study the frequency of primary HHV-7 infection associated with E.S was similar to that reported for Japan 17 , around 10.0%. Our results showed that HHV-7 DNA detection in blood (serum) was lower than those reported from other studies that used either saliva 5, 16 or peripheral blood mononuclear cells 13, 37 . It is worth to point out that saliva and peripheral blood mononuclear cells are associated with sites of persistence to the HHV-7 8, 30, 37 , where a high virus DNA concentration is expected. It is also worth underscoring the fact that detection of HHV-7 DNA in serum and plasma obtained during acute phase of disease is a marker of primary infection 28, 36 .
In our study the patients with primary HHV-7 infections presented with clinical features resembling those of E.S, in general characterized as clinically moderate. Symptoms included high fever and subsequent maculopapular skin rash lasting 24 to 72 hours. Of note, such a typical E.S is often associated with primary HHV-6 infections 40 and, less frequently, with HHV-7 infection. Severe neurological complications due to invasion of the central nervous system, mainly those associated with E.S, as demonstrated by other authors 23, 25, 33, 35 , were not recorded in the present study.
Our results suggest that HHV-7 infection should be sought in cases of exanthematous illnesses affecting both children and adults in our region and elsewhere. The fact that pathogens other that HHV-7 (including some arboviruses) were ruled out as a likely cause for the exanthematous diseases among our patients sustains our proposed causal relationship between HHV-7 and E.S in our region. To our knowledge, these are the first findings in North Brazil that provide evidence in support to the role that HHV-7 might have as a cause of exanthematous illnesses during childhood. de idade) a 80,0% (masculino, 8-10 anos de idade) foram observadas no subgrupo positivo para IgG. Um subgrupo (n = 131) de pacientes com anticorpos IgM ou IgG foi examinado quanto a presença de DNA para o HHV-7 pela técnica da reação em cadeia da polimerase/ "nested" PCR. Infecção recente/ativa para o HHV-7 ocorreu em 11,0% (6/55) dos pacientes cujas amostras apresentaram anticorpos IgM específicos para o HHV-7. Em um subgrupo (n = 76) de pacientes com altos níveis de anticorpos IgG para o HHV-7 (título > 1: 160) não foi detectada a presença de DNA em seus soros pelo PCR/ "nested" PCR. Entre as seis infecções recentes/ativas, quatro indivíduos com menos de um ano e dois com 3 e 6 anos de idade apresentaram típico exantema súbito (E.S) definido por febre elevada (> 38,0 ºC) com duração de 24 a 72 horas, acompanhandose de erupção cutânea maculopapular.
RESUMO
Nossos resultados ressaltam a necessidade de procurarmos a infecção pelo HHV-7 em pacientes portadores de doença exantemática, particularmente naquelas apresentações típicas de E.S. O HHV-7 parece emergir como um novo patógeno associado a quadros exantemáticos em nossa região.
